SlideShare uma empresa Scribd logo
1 de 35
Baixar para ler offline
SHOCK
Student: Dr. Eliz Achhami(Intern)
Shree Birendra Hospital
Objectives
• Definition
• Types
• Pathophysiology
• Clinical features
• Management aspects
Definition
• Shock is a physiologic state characterized by
systemic reduction in tissue perfusion,
resulting in decreased tissue oxygen delivery.
Demand Supply  Demand  Supply
ShockNormal
Types of Shock
Shock
obstructive
Cardiogenic
Distributive
Hypovolemic
HYPOVOLAEMIC ETIOLOGY
Hemorrhagic
• Trauma
• Gastrointestinal
• Retroperitoneal
Non-Hemorrhagic(Fluid
depletion)
External fluid loss
- Dehydration
- Vomiting
- Diarrhea
• Interstitial fluid redistribution
- Thermal injury
- Trauma
- Anaphylaxis
• Valvular heart disease
• Myocardial infarction.
• Cardiac arrhythmias.
• Cardiomyopathy
CARDIOGENIC ETIOLOGY
OBSTRUCTIVE ETIOLOGY
• Cardiac Tamponade
• Constrictive pericarditis
• Pulmonary Embolism
• Tension Pneumothorax
• Air embolism
NEUROGENIC ETIOLOGY
• Paraplegia.
• Quadriplegia.
• Trauma to spinal cord.
• Spinal anesthesia.
ANAPHYLACTIC ETIOLOGY
• Injections - Penicillins.
• Anaesthetics
• Stings.
• Shelfish.
• Gram +
• Gram -
• Fungi / Virus
• Protozoa
SEPTIC ETIOLOGY
Bacterial
ENDOCRINE ETIOLOGY
• Hypo & Hyperthyroidism.
• Adrenal insufficiency.
Pathophysiology of Shock
Cells switch from aerobic to anaerobic metabolism
lactic acid production
Cell function ceases & swells
membrane becomes more permeable
electrolytes & fluids seep in & out of cell
Na+/K+ pump impaired
mitochondria damage
cell death
COMPENSATORY MECHANISMS:
Sympathetic Nervous System (SNS)-
Adrenal Response
Neurohormonal response
Stimulated by baroreceptors
 Increased heart rate
 Increased contractility
 Vasoconstriction
(Afterload)
 Increased Preload
Hormonal: Renin-angiotension
system
Decrease renal perfusion
Releases renin--angiotension I
angiotension II ---potent
vasoconstriction & releases
aldosterone adrenal cortex
sodium & water retention (
intravascular volume )
 SNS - Hormonal:
Antidiuretic Hormone
 Osmoreceptors in
hypothalamus stimulated
 ADH released by
Posterior pituitary gland
 Vasopressor effect to
increase BP
 Acts on renal tubules to
retain water
SNS - Hormonal: Adrenal
Cortex
 Anterior pituitary releases
adrenocorticotropic hormone
(ACTH)
 Stimulates adrenal Cortex to
release glucorticoids
 Blood sugar increases to meet
increased metabolic needs
Shock – Effects on Organ
• Heart – ↓ CO / hypotension / myocardial
depressants
• Lung - ↓gas exchange / tachypnoea / pulmonary
edema
• Endocrine – ADH → ↑ reabsorption of water
• CNS – perfusion ↓ – drowsy
• Blood - Coagulation abnormalities – DIC
• Renal - ↓ GFR - ↓ urine output
• GIT – mucosal ischaemia – bleeding & hepatic - ↑
enzyme levels
Stages of shock
• Initial : The cells become leaky and switch to
anaerobic metabolism.
• Non-progressive:(compensated stage)
Attempt to correct the metabolic upset of
shock.
• Progressive: (decompensated stage )
Eventually the compensation will begin to fail.
• Refractory : Organs fail and the shock can no
longer be reversed.
Clinical features
• Features of shock depend on the degree of loss of
volume & on duration of shock.
• Types
– Mild shock.
– Moderate shock.
– Severe shock.
SHOCK
[ Management ]
Diagnosis and Evaluation
Laboratory
 Hb, WBC, platelets
 PT/PTT
 Electrolytes, arterial blood gases
 BUN, Creatinine
 Calcium , Magnesium
 Serum lactate
 ECG
Invasive Monitoring
Arterial pressure catheter
CVP monitoring
Pulmonary artery catheter (+/- RVEF,
oximetry)
Goals of Resuscitation
• Overall goal:
– increase O2 delivery
– decrease demand
Treatment
O2 content Cardiac
output
Blood
pressure
Immediate Goals in Shock
Hemodynamic support MAP > 60mmHg
PAWP = 12 - 18 mmHg
Cardiac Index > 2.2 L/min/m2
Maintain oxygen delivery Hemoglobin > 9 g/dL
Arterial saturation > 92%
Supplemental oxygen and
mechanical ventilation
Reversal of oxygen dysfunction Decreasing lactate (< 2.2 mM/L)
Maintain urine output
` Reverse encephalopathy
Improving renal, liver function
tests
Principles of Resuscitation
• A: Airway
– patent upper airway
• B: Breathing
– adequate ventilation and oxygenation
• C: Circulation
– placement of adequate IV access
• cardiac function
• oxygenation
Fluid therapy
Crystalloids
• Lactated Ringer’s solution
• Normal saline
Colloids
• Hetastarch
• Albumin
Packed red blood cells
Infuse to physiologic endpoints
Hypovolemic Shock
Restore circulating volume with blood, colloid, or crystalloid
Control hemorrhage
Vasoconstrictor if BP still low after volume loading
Identify source of blood or fluid loss:
• Endoscopy/colonoscopy
• Angiography
• CT/MRI scan
Cardiogenic Shock
o Goal of Management :
o Treat Reversible Causes
o Protect ischemic myocardium
o Improve tissue perfusion
o Limiting/reducing myocardial damage during Myocardial
Infarction:
 Increased pumping action & decrease workload of the heart
• Inotropic agents/Vasoactive drugs
• Intra-aortic balloon pump
• Cautious administration of fluids
• Transplantation
 Consider thrombolytics, angioplasty in specific cases
Extra-cardiac Obstructive Shock
Pericardial tamponade
• pericardiocentesis
• surgical drainage (if needed)
Pulmonary embolism
• heparin
• ventilation/perfusion lung scan
• pulmonary angiography
• consider:
• thrombolytic therapy
• embolectomy at surgery
Distributive Shock
Anaphylactic Shock
– Early recognition, treat aggressively
– Airway support
– IV epinephrine (open airways)
– Antihistamines
– Corticosteroids
– Immediate withdrawal of antigen if possible
– Judicious crystalloid administration
– Vasopressors to maintain organ perfusion
– Positive inotropes
Management of septic shock
A. Initial Resuscitation
• For sepsis induced hypoperfusion, at least
30ml/kg of IV crstalloid fluid should be given
within the first 3 hour.
• Additional fluids be guided by frequent
reassessment hemodynamic status.
B. Diagnosis
• Appropriate routine microbiological cultures.
C. Antimicrobial therapy
• IV antimicrobials as soon as possible after
recognition and within one hour for sepsis and
shock.
• Empiric broad spectrum therapy to cover all
pathogens.
• Antimicrobial treatment duration of 7 to 10 days
is adequate for most of infections.
D. Source control
• Recommend that a specific anatomic diagnosis be identified or
excluded as rapidly as possible in patients with sepsis or septic
shock, and that any required source control intervention be
implemented as soon as medically and logistically practical after
the diagnosis is made.
E. Fluid therapy
• recommend crystalloids as the fluid of choice for initial
resuscitation and subsequent intravascular volume replacement
• Use albumin in addition to crystalloids (if require substantial
amounts of crystalloids)
F. Vasoactive agents
• Recommend norepinephrine as the first choice
vasopressor.
• Suggest adding either vasopressin (up to 0.03 U/min)
or epinephrine to norepinephrine with the intent of
raising MAP to target, or adding vasopressin (up to
0.03 U/min) to decrease norepinephrine dosage.
• Use dobutamine in patient who show evidence of
persistent hypo perfusion despite adequate fliud and
vasopressors.
End Points of Resuscitation
 Classic / Traditional
 Restoration of blood pressure
 Normalization of heart rate
and urine output
 Appropriate mental status
 Improved / Global
 All of the above plus
 Normalization of serum
lactate levels
 Resolution of base deficit
 Goal directed approach
 Urine output > 0.5 mL/kg/hr
 CVP 5 -10 cm H2o
 MAP 65 to 90 mmHg
 Central venous oxygen
concentration > 70%
Thank you

Mais conteúdo relacionado

Mais procurados (20)

Hypovolemic Shock
Hypovolemic ShockHypovolemic Shock
Hypovolemic Shock
 
4-hypovolemic-shock.ppt
4-hypovolemic-shock.ppt4-hypovolemic-shock.ppt
4-hypovolemic-shock.ppt
 
Physiology shock
Physiology shockPhysiology shock
Physiology shock
 
Shock - Pathophysiology / Types & Management
Shock - Pathophysiology / Types & ManagementShock - Pathophysiology / Types & Management
Shock - Pathophysiology / Types & Management
 
Shock and hemorrhage
Shock and hemorrhageShock and hemorrhage
Shock and hemorrhage
 
SHOCK
SHOCKSHOCK
SHOCK
 
Pathophysiology of shock
Pathophysiology  of  shockPathophysiology  of  shock
Pathophysiology of shock
 
Myocardial Infarction
Myocardial Infarction Myocardial Infarction
Myocardial Infarction
 
Shock
Shock	Shock
Shock
 
Shock
Shock Shock
Shock
 
shock
shockshock
shock
 
Hemorrhage & Shock
Hemorrhage & ShockHemorrhage & Shock
Hemorrhage & Shock
 
Shock and its management
Shock and its  managementShock and its  management
Shock and its management
 
MANAGEMENT OF SHOCK
MANAGEMENT OF SHOCKMANAGEMENT OF SHOCK
MANAGEMENT OF SHOCK
 
Edema
EdemaEdema
Edema
 
Haemorrhage (original)
Haemorrhage (original)Haemorrhage (original)
Haemorrhage (original)
 
Pathophysiology and management of shock
 Pathophysiology and management of shock Pathophysiology and management of shock
Pathophysiology and management of shock
 
Sepsis – pathophysiology and management
Sepsis – pathophysiology and managementSepsis – pathophysiology and management
Sepsis – pathophysiology and management
 
Shock
ShockShock
Shock
 
Shock
ShockShock
Shock
 

Semelhante a Shock (20)

Shock
Shock Shock
Shock
 
Shock its types and management
Shock its types and managementShock its types and management
Shock its types and management
 
hypovolemic shock.pdf
hypovolemic shock.pdfhypovolemic shock.pdf
hypovolemic shock.pdf
 
Shock.pptx
Shock.pptxShock.pptx
Shock.pptx
 
Presentation on shock and its types.pptx
Presentation on shock and its types.pptxPresentation on shock and its types.pptx
Presentation on shock and its types.pptx
 
Pathophysiology of shock and its management
Pathophysiology of shock and its managementPathophysiology of shock and its management
Pathophysiology of shock and its management
 
Shock
ShockShock
Shock
 
My shock overview
My shock overviewMy shock overview
My shock overview
 
Shock.pptx
Shock.pptxShock.pptx
Shock.pptx
 
Shock.pptx
Shock.pptxShock.pptx
Shock.pptx
 
Shock
ShockShock
Shock
 
Shock
ShockShock
Shock
 
shock and its management copy
shock and its management   copyshock and its management   copy
shock and its management copy
 
2. Hypovolemic, Septic and Cardiogenic Shock.pptx
2. Hypovolemic, Septic and Cardiogenic Shock.pptx2. Hypovolemic, Septic and Cardiogenic Shock.pptx
2. Hypovolemic, Septic and Cardiogenic Shock.pptx
 
Shock
ShockShock
Shock
 
Shock in children
Shock in childrenShock in children
Shock in children
 
Shock nekaba
Shock nekabaShock nekaba
Shock nekaba
 
CVS-_Therapy_of_Shock.pdf
CVS-_Therapy_of_Shock.pdfCVS-_Therapy_of_Shock.pdf
CVS-_Therapy_of_Shock.pdf
 
8. shock
8. shock8. shock
8. shock
 
Shock
ShockShock
Shock
 

Último

Giftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-KnowledgeGiftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-Knowledgeassessoriafabianodea
 
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara RajendranMusic Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara RajendranTara Rajendran
 
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdfMedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdfSasikiranMarri
 
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptxPERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptxdrashraf369
 
Plant Fibres used as Surgical Dressings PDF.pdf
Plant Fibres used as Surgical Dressings PDF.pdfPlant Fibres used as Surgical Dressings PDF.pdf
Plant Fibres used as Surgical Dressings PDF.pdfDivya Kanojiya
 
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
COVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptxCOVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptx
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptxBibekananda shah
 
World-Health-Day-2024-My-Health-My-Right.pptx
World-Health-Day-2024-My-Health-My-Right.pptxWorld-Health-Day-2024-My-Health-My-Right.pptx
World-Health-Day-2024-My-Health-My-Right.pptxEx WHO/USAID
 
Radiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxRadiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxDr. Dheeraj Kumar
 
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurMETHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurNavdeep Kaur
 
Apiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptApiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptkedirjemalharun
 
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...MehranMouzam
 
epilepsy and status epilepticus for undergraduate.pptx
epilepsy and status epilepticus  for undergraduate.pptxepilepsy and status epilepticus  for undergraduate.pptx
epilepsy and status epilepticus for undergraduate.pptxMohamed Rizk Khodair
 
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisVarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisGolden Helix
 
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptxPresentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptxpdamico1
 
PULMONARY EDEMA AND ITS MANAGEMENT.pdf
PULMONARY EDEMA AND  ITS  MANAGEMENT.pdfPULMONARY EDEMA AND  ITS  MANAGEMENT.pdf
PULMONARY EDEMA AND ITS MANAGEMENT.pdfDolisha Warbi
 
Tans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptxTans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptxKezaiah S
 
Introduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiIntroduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiGoogle
 
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners
 
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
PNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdfPNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdf
PNEUMOTHORAX AND ITS MANAGEMENTS.pdfDolisha Warbi
 
Basic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdfBasic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdfDivya Kanojiya
 

Último (20)

Giftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-KnowledgeGiftedness: Understanding Everyday Neurobiology for Self-Knowledge
Giftedness: Understanding Everyday Neurobiology for Self-Knowledge
 
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara RajendranMusic Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
 
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdfMedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
MedDRA-A-Comprehensive-Guide-to-Standardized-Medical-Terminology.pdf
 
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptxPERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
 
Plant Fibres used as Surgical Dressings PDF.pdf
Plant Fibres used as Surgical Dressings PDF.pdfPlant Fibres used as Surgical Dressings PDF.pdf
Plant Fibres used as Surgical Dressings PDF.pdf
 
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
COVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptxCOVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptx
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
 
World-Health-Day-2024-My-Health-My-Right.pptx
World-Health-Day-2024-My-Health-My-Right.pptxWorld-Health-Day-2024-My-Health-My-Right.pptx
World-Health-Day-2024-My-Health-My-Right.pptx
 
Radiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxRadiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptx
 
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurMETHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
 
Apiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptApiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.ppt
 
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
 
epilepsy and status epilepticus for undergraduate.pptx
epilepsy and status epilepticus  for undergraduate.pptxepilepsy and status epilepticus  for undergraduate.pptx
epilepsy and status epilepticus for undergraduate.pptx
 
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisVarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
 
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptxPresentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
Presentation for Bella Mahl 2024-03-28-24-MW-Overview-Bella.pptx
 
PULMONARY EDEMA AND ITS MANAGEMENT.pdf
PULMONARY EDEMA AND  ITS  MANAGEMENT.pdfPULMONARY EDEMA AND  ITS  MANAGEMENT.pdf
PULMONARY EDEMA AND ITS MANAGEMENT.pdf
 
Tans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptxTans femoral Amputee : Prosthetics Knee Joints.pptx
Tans femoral Amputee : Prosthetics Knee Joints.pptx
 
Introduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiIntroduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali Rai
 
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
 
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
PNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdfPNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdf
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
 
Basic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdfBasic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdf
 

Shock

  • 1. SHOCK Student: Dr. Eliz Achhami(Intern) Shree Birendra Hospital
  • 2. Objectives • Definition • Types • Pathophysiology • Clinical features • Management aspects
  • 3. Definition • Shock is a physiologic state characterized by systemic reduction in tissue perfusion, resulting in decreased tissue oxygen delivery.
  • 4. Demand Supply  Demand  Supply ShockNormal
  • 6. HYPOVOLAEMIC ETIOLOGY Hemorrhagic • Trauma • Gastrointestinal • Retroperitoneal Non-Hemorrhagic(Fluid depletion) External fluid loss - Dehydration - Vomiting - Diarrhea • Interstitial fluid redistribution - Thermal injury - Trauma - Anaphylaxis
  • 7. • Valvular heart disease • Myocardial infarction. • Cardiac arrhythmias. • Cardiomyopathy CARDIOGENIC ETIOLOGY
  • 8. OBSTRUCTIVE ETIOLOGY • Cardiac Tamponade • Constrictive pericarditis • Pulmonary Embolism • Tension Pneumothorax • Air embolism
  • 9. NEUROGENIC ETIOLOGY • Paraplegia. • Quadriplegia. • Trauma to spinal cord. • Spinal anesthesia.
  • 10. ANAPHYLACTIC ETIOLOGY • Injections - Penicillins. • Anaesthetics • Stings. • Shelfish.
  • 11. • Gram + • Gram - • Fungi / Virus • Protozoa SEPTIC ETIOLOGY Bacterial
  • 12. ENDOCRINE ETIOLOGY • Hypo & Hyperthyroidism. • Adrenal insufficiency.
  • 13. Pathophysiology of Shock Cells switch from aerobic to anaerobic metabolism lactic acid production Cell function ceases & swells membrane becomes more permeable electrolytes & fluids seep in & out of cell Na+/K+ pump impaired mitochondria damage cell death
  • 14. COMPENSATORY MECHANISMS: Sympathetic Nervous System (SNS)- Adrenal Response Neurohormonal response Stimulated by baroreceptors  Increased heart rate  Increased contractility  Vasoconstriction (Afterload)  Increased Preload Hormonal: Renin-angiotension system Decrease renal perfusion Releases renin--angiotension I angiotension II ---potent vasoconstriction & releases aldosterone adrenal cortex sodium & water retention ( intravascular volume )
  • 15.  SNS - Hormonal: Antidiuretic Hormone  Osmoreceptors in hypothalamus stimulated  ADH released by Posterior pituitary gland  Vasopressor effect to increase BP  Acts on renal tubules to retain water SNS - Hormonal: Adrenal Cortex  Anterior pituitary releases adrenocorticotropic hormone (ACTH)  Stimulates adrenal Cortex to release glucorticoids  Blood sugar increases to meet increased metabolic needs
  • 16. Shock – Effects on Organ • Heart – ↓ CO / hypotension / myocardial depressants • Lung - ↓gas exchange / tachypnoea / pulmonary edema • Endocrine – ADH → ↑ reabsorption of water • CNS – perfusion ↓ – drowsy • Blood - Coagulation abnormalities – DIC • Renal - ↓ GFR - ↓ urine output • GIT – mucosal ischaemia – bleeding & hepatic - ↑ enzyme levels
  • 17. Stages of shock • Initial : The cells become leaky and switch to anaerobic metabolism. • Non-progressive:(compensated stage) Attempt to correct the metabolic upset of shock. • Progressive: (decompensated stage ) Eventually the compensation will begin to fail. • Refractory : Organs fail and the shock can no longer be reversed.
  • 18. Clinical features • Features of shock depend on the degree of loss of volume & on duration of shock. • Types – Mild shock. – Moderate shock. – Severe shock.
  • 20. Diagnosis and Evaluation Laboratory  Hb, WBC, platelets  PT/PTT  Electrolytes, arterial blood gases  BUN, Creatinine  Calcium , Magnesium  Serum lactate  ECG
  • 21. Invasive Monitoring Arterial pressure catheter CVP monitoring Pulmonary artery catheter (+/- RVEF, oximetry)
  • 22. Goals of Resuscitation • Overall goal: – increase O2 delivery – decrease demand Treatment O2 content Cardiac output Blood pressure
  • 23. Immediate Goals in Shock Hemodynamic support MAP > 60mmHg PAWP = 12 - 18 mmHg Cardiac Index > 2.2 L/min/m2 Maintain oxygen delivery Hemoglobin > 9 g/dL Arterial saturation > 92% Supplemental oxygen and mechanical ventilation Reversal of oxygen dysfunction Decreasing lactate (< 2.2 mM/L) Maintain urine output ` Reverse encephalopathy Improving renal, liver function tests
  • 24. Principles of Resuscitation • A: Airway – patent upper airway • B: Breathing – adequate ventilation and oxygenation • C: Circulation – placement of adequate IV access • cardiac function • oxygenation
  • 25. Fluid therapy Crystalloids • Lactated Ringer’s solution • Normal saline Colloids • Hetastarch • Albumin Packed red blood cells Infuse to physiologic endpoints
  • 26. Hypovolemic Shock Restore circulating volume with blood, colloid, or crystalloid Control hemorrhage Vasoconstrictor if BP still low after volume loading Identify source of blood or fluid loss: • Endoscopy/colonoscopy • Angiography • CT/MRI scan
  • 27. Cardiogenic Shock o Goal of Management : o Treat Reversible Causes o Protect ischemic myocardium o Improve tissue perfusion o Limiting/reducing myocardial damage during Myocardial Infarction:  Increased pumping action & decrease workload of the heart • Inotropic agents/Vasoactive drugs • Intra-aortic balloon pump • Cautious administration of fluids • Transplantation  Consider thrombolytics, angioplasty in specific cases
  • 28. Extra-cardiac Obstructive Shock Pericardial tamponade • pericardiocentesis • surgical drainage (if needed) Pulmonary embolism • heparin • ventilation/perfusion lung scan • pulmonary angiography • consider: • thrombolytic therapy • embolectomy at surgery
  • 29. Distributive Shock Anaphylactic Shock – Early recognition, treat aggressively – Airway support – IV epinephrine (open airways) – Antihistamines – Corticosteroids – Immediate withdrawal of antigen if possible – Judicious crystalloid administration – Vasopressors to maintain organ perfusion – Positive inotropes
  • 30. Management of septic shock A. Initial Resuscitation • For sepsis induced hypoperfusion, at least 30ml/kg of IV crstalloid fluid should be given within the first 3 hour. • Additional fluids be guided by frequent reassessment hemodynamic status. B. Diagnosis • Appropriate routine microbiological cultures.
  • 31. C. Antimicrobial therapy • IV antimicrobials as soon as possible after recognition and within one hour for sepsis and shock. • Empiric broad spectrum therapy to cover all pathogens. • Antimicrobial treatment duration of 7 to 10 days is adequate for most of infections.
  • 32. D. Source control • Recommend that a specific anatomic diagnosis be identified or excluded as rapidly as possible in patients with sepsis or septic shock, and that any required source control intervention be implemented as soon as medically and logistically practical after the diagnosis is made. E. Fluid therapy • recommend crystalloids as the fluid of choice for initial resuscitation and subsequent intravascular volume replacement • Use albumin in addition to crystalloids (if require substantial amounts of crystalloids)
  • 33. F. Vasoactive agents • Recommend norepinephrine as the first choice vasopressor. • Suggest adding either vasopressin (up to 0.03 U/min) or epinephrine to norepinephrine with the intent of raising MAP to target, or adding vasopressin (up to 0.03 U/min) to decrease norepinephrine dosage. • Use dobutamine in patient who show evidence of persistent hypo perfusion despite adequate fliud and vasopressors.
  • 34. End Points of Resuscitation  Classic / Traditional  Restoration of blood pressure  Normalization of heart rate and urine output  Appropriate mental status  Improved / Global  All of the above plus  Normalization of serum lactate levels  Resolution of base deficit  Goal directed approach  Urine output > 0.5 mL/kg/hr  CVP 5 -10 cm H2o  MAP 65 to 90 mmHg  Central venous oxygen concentration > 70%